Evidence map›Paper›PMID 20237900›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2010

Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region.

Aybike Birerdinc, Elizabeth Nohelty, Andrey Marakhonov, Ganiraju Manyam, Ivan Panov, Stephanie Coon, Eugene Nikitin, Mikhail Skoblov, Vikas Chandhoke, Ancha Baranova

Open access · hybridAbstract read
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. The emerging role of the KCTD proteins in cancer.Cell communication and signaling : CCS · 2021
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Aybike BirerdincMolecular Biology and Microbiology Department, College of Science, George Mason University, David King Hall, MSN 3E1, Fairfax, VA 22030, USA.
Elizabeth Nohelty
Andrey Marakhonov
Ganiraju Manyam
Ivan Panov
Stephanie Coon
Eugene Nikitin
Mikhail Skoblov
Vikas Chandhoke
Ancha Baranova
George Mason University · USResearch Centre for Medical Genetics · RUState Research Center of the Russian Federation · RU

Funding

KCNRG gene as candidate tumor suppressor for CLL and MMR15CA113331 · NCI · GEORGE MASON UNIVERSITY · PI BARANOVA, ANNA V · 2005 to 2005
$213k
NCI NIH HHS R15 CA113331
6 · The paper itself

Abstract

Deletion of 13q14.3 and a candidate gene KCNRG (potassium channel regulating gene) is the most frequent chromosomal abnormality in B-cell chronic lymphocytic leukemia and is a common finding in multiple myeloma (MM). KCNRG protein may interfere with the normal assembly of the K+ channel proteins causing the suppression of Kv currents. We aimed to examine possible role of KCNRG haploinsufficiency in chronic lymphocytic leukemia (CLL) and MM cells. We performed detailed genomic analysis of the KCNRG locus; studied effects of the stable overexpression of KCNRG isoforms in RPMI-8226, HL-60, and LnCaP cells; and evaluated relative expression of its transcripts in various human lymphomas. Three MM cell lines and 35 CLL PBL samples were screened for KCNRG mutations. KCNRG exerts growth suppressive and pro-apoptotic effects in HL-60, LnCaP, and RPMI-8226 cells. Direct sequencing of KCNRG exons revealed point mutation delT in RPMI-8226 cell line. Levels of major isoform of KCNRG mRNA are lower in DLBL lymphomas compared to normal PBL samples, while levels of its minor mRNA are decreased across the broad range of the lymphoma types. The haploinsufficiency of KCNRG might be relevant to the progression of CLL and MM at least in a subset of patients.

Indexed as

ApoptosisChromosome MappingChromosomes, Human, Pair 13Genes, Tumor SuppressorAnimalsCell MovementCell ProliferationHL-60 CellsHumansLeukemia, Lymphocytic, Chronic, B-CellMiceMultiple MyelomaNeoplasm InvasivenessPolymerase Chain ReactionPotassium ChannelsProtein IsoformsKCNRG protein, humanPotassium ChannelsProtein IsoformsRNA, Messenger

Identifiers

PMID20237900
PMCPMC2803748
OpenAlexW1988300145

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.